Pune, India, March 14, 2022 (GLOBE NEWSWIRE) -- As per the conclusive views of experts, worldwide generic injectable market size reached a value of USD 134 billion in 2021 and is anticipated to register a healthy y-o-y growth rate throughout the forecast period 2022-2027.
The research piece encompasses a vivid depiction of the entire ecosystem of the industry across the various geographies, as well as the other sub-markets. Proceeding further, it makes a study of the competitive dynamics in this vertical to help both existing and new players draft beneficial strategies for the upcoming years.
Patent expiration of branded drugs, increasing approvals for generic drugs, expanding elderly population, and increasing cases of fatal diseases are stimulating the market growth. Relatively lower costs than branded drugs and widespread application in the treatment of major ailments like CVDs, cancer, and diabetes are favoring the use of generic injectable drugs.
Request Sample copy of this Report @ https://www.marketstudyreport.com/request-a-sample/4814124/
COVID-19 impact overview
The pandemic negatively impacted the industry as healthcare services, hospitals, and drug manufacturers faced restrictions such as social distancing, border closures, and travel restrictions. Many injectable drugs couldn’t reach the market on time due to the disruption in both supply and demand.
Although the pharmaceutical industry was less affected than others, milder impacts were still felt. Delays in clinical trials and restrictions on accessing laboratories for researchers slowed the progress of the global generic injectables industry.
Geographical landscape summary
North America, Latin America, Asia Pacific, and Europe are the major regional contributors to the market growth. Asia Pacific market is slated to register a robust growth rate over the analysis period, creditable to rising emphasis of companies on complex generics and increasing uptake of generic injectables, especially in cost-sensitive areas like India. Besides, high prevalence of various chronic diseases continues to add to the market demand.
To access a sample copy or view this report in detail along with the table of contents, please click the link below:
Competitive landscape review
Nichi-Iko Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., Gland Pharma Ltd., Hikma Pharmaceuticals plc, Amneal Pharmaceuticals LLC, Fresenius SE & Co KGaA, Baxter International Inc., Sanofi S.A., Novartis AG, and Pfizer Inc. are the major contenders influencing global generic injectables market dynamics.
Major players are strengthening their position by new product launches, R&D investments, as well as mergers & partnerships. For instance, Pfizer Inc in 2021 partnered with Eli Lily and Company to get approval for tanezumab, a generic injectable drug for treating osteoarthritis pain, in the U.S.
Global Generic Injectables Market, by Molecular Type (Value, USD, 2017-2027)
- Small Molecule
- Large Molecule
Global Generic Injectables Market, by Therapeutic Area (Value, USD, 2017-2027)
- Anti-infectives
- Oncology
- Cardiovascular
- Diabetes
Global Generic Injectables Market, by Container (Value, USD, 2017-2027)
- Vials
- Pre-filled Syringes
- Ampoules
- Others
Global Generic Injectables Market, by Geography (Value, USD, 2017-2027)
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Italy
Asia Pacific
- India
- China
- Japan
- Australia
Global Generic Injectables Market Company Profiles (Value, USD, 2017-2027)
- Nichi-Iko Pharmaceutical Co. Ltd.
- Teva Pharmaceutical Industries Ltd.
- Gland Pharma Ltd.
- Hikma Pharmaceuticals plc
- Amneal Pharmaceuticals LLC
- Fresenius SE & Co KGaA
- Baxter International Inc.
- Sanofi S.A.
- Novartis AG
- Pfizer Inc.
Table of Content:
1. Report Scope and Methodology
1.1 Scope of the Report
1.2 Research Methodology
1.3 Executive Summary
2. Strategic Recommendations
3. Generic Injectables Market: Product Overview
4. Global Generic Injectables Market: An Analysis
4.1 Market Size, By Value, 2017-2027
4.2 Global Generic Injectables Market: Growth & Forecast
4.3 Impact of COVID-19 on Generic Injectables Market
5. Global Generic Injectables Market Segmentation, By Molecule Type (Value)
5.1 Competitive Scenario of Global Generic Injectables Market: By Molecule Type
5.2 Global Generic Injectables Market: Segment Analysis
5.3 By Small Molecule - Market Size and Forecast (2017-2027)
5.4 By Large Molecule - Market Size and Forecast (2017-2027)
6. Global Generic Injectables Market Segmentation, By Therapeutic Area (Value)
6.1 Competitive Scenario of Global Generic Injectables Market: By Therapeutic Area (2021 & 2027)
6.2 Global Generic Injectables Market: Segment Analysis
6.3 By Oncology - Market Size and Forecast (2017-2027)
6.4 By Anti-infectives - Market Size and Forecast (2017-2027)
6.5 By Cardiovascular - Market Size and Forecast (2017-2027)
7. Global Generic Injectables Market Segmentation, By Container (Value)
7.1 Competitive Scenario of Global Generic Injectables Market: By Container (2021 & 2027)
7.2 Global Generic Injectables Market: Segment Analysis
7.3 By Vials - Market Size and Forecast (2017-2027)
7.4 By Ampoules - Market Size and Forecast (2017-2027)
7.5 By Pre-filled Syringes - Market Size and Forecast (2017-2027)
8. Global Generic Injectables Market: Regional Analysis
8.1 Competitive Scenario of Global Generic Injectables Market: By Region (2021 & 2027)
9. North America Generic Injectables Market: An Analysis (2017-2027)
9.1 North America Generic Injectables Market: Size and Forecast (2017-2027), By Value
9.2 North America Generic Injectables Market - Prominent Companies
9.3 Market Segmentation By Molecule Type (Small Molecule and Large Molecule)
9.4 Market Segmentation By Therapeutic Area (Oncology, Anti-infectives, Cardiovascular, Diabetes and Others)
9.5 Market Segmentation By Container (Vials, Ampoules, Pre-filled Syringes and Others)
10. Europe Generic Injectables Market: An Analysis (2017-2027)
10.1 Europe Generic Injectables Market by value: Size and Forecast (2017-2027)
10.2 Europe Generic Injectables Market: Prominent Companies
10.3 Market Segmentation By Molecule Type (Small Molecule and Large Molecule)
10.4 Market Segmentation By Therapeutic Area (Oncology, Anti-infectives, Cardiovascular, Diabetes and Others)
10.5 Market Segmentation By Container (Vials, Ampoules, Pre-filled Syringes and Others)
11. Asia Pacific Generic Injectables Market: An Analysis (2017-2027)
11.1 Asia Pacific Generic Injectables Market by value: Size and Forecast (2017-2027)
11.2 Asia Pacific Generic Injectables Market: Prominent Companies
11.3 Market Segmentation By Molecule Type (Small Molecule and Large Molecule)
11.4 Market Segmentation By Therapeutic Area (Oncology, Anti-infectives, Cardiovascular, Diabetes and Others)
11.5 Market Segmentation By Container (Vials, Ampoules, Pre-filled Syringes and Others)
12. Global Generic Injectables Market Dynamics
12.1 Global Generic Injectables Market Drivers
12.2 Global Generic Injectables Market Restraints
12.3 Global Generic Injectables Market Trends
13. Market Attractiveness and Strategic Analysis
13.1 Market Attractiveness Chart of Global Generic Injectables Market - By Molecule Type (Year 2027)
13.2 Market Attractiveness Chart of Global Generic Injectables Market - By Therapeutic Area (Year 2027)
13.3 Market Attractiveness Chart of Global Generic Injectables Market ?? By Container (Year 2027)
13.4 Market Attractiveness Chart of Global Generic Injectables Market ?? By Region (Year 2027)
14. Competitive Landscape
Related Report:
Connected Drug Delivery Devices Market Size, COVID-19 Impact Analysis, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2021 - 2027
The connected drug delivery devices market is expected to grow significantly by 2027 on account of technological advances in the sector. In addition, rising incidences of chronic diseases around the globe are expected to further fuel market demand over the forecast period. Surging preference for home-based patient care among patients who require regular therapy has boosted industry expansion in recent years. Moreover, enhanced efficacy of connected drug delivery devices compared to manual devices has augmented market adoption. From the regional point of view, the Latin America connected drug delivery devices market accounted for nearly 9.9% of the overall industry revenue in 2020. Meanwhile, the Middle East & Africa connected drug delivery devices market is projected to exhibit robust growth through 2027, progressing at a CAGR of more than 35.9% over the study timeframe.
About US:
Market Study Report is a hub for market intelligence products and services.
We streamline the purchase of your market research reports and services through a single integrated platform by bringing all the major publishers and their services at one place.
Our customers partner with Market Study Report, to ease their search and evaluation of market intelligence products and services and in turn focus on their company's core activities.
If you are looking for research reports on global or regional markets, competitive information, emerging markets and trends or just looking to stay on top of the curve then Market Study Report, is the platform that can help you in achieving any of these objectives.
